Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             35 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A longitudinal study assessing the impact of elexacaftor/tezacaftor/ivacaftor on gut transit and function in people with cystic fibrosis using magnetic resonance imaging (MRI) Yule, Alexander

23 5 p. 984-990
artikel
2 An emotional journey: caregiver experiences with gastrostomy tube decision-making for children with cystic fibrosis Dickinson, Kimberly M.

23 5 p. 1000-1006
artikel
3 Are demographic findings really possible from reports in a spontaneous reporting system? Noguchi, Yoshihiro

23 5 p. 1031
artikel
4 Association between biomarkers of tobacco smoke exposure and clinical efficacy of ivacaftor in the G551D observational trial (GOAL) Baker, Elizabeth

23 5 p. 959-966
artikel
5 Association between CFTR modulators and changes in iron deficiency markers in cystic fibrosis Jia, Shijing

23 5 p. 878-884
artikel
6 Azithromycin reduces bronchial wall thickening in infants with cystic fibrosis Chen, Yuxin

23 5 p. 870-873
artikel
7 Beyond insulin: Unraveling the complex interplay of ER stress, oxidative damage, and CFTR modulation in CFRD Umashankar, Bala

23 5 p. 842-852
artikel
8 Clinical and radiological improvement of cavitary Mycobacteroides abscessus disease in cystic fibrosis following initiation of elexacaftor/tezacaftor/ivacaftor Gavey, Roderick

23 5 p. 1024-1026
artikel
9 Clinical outcomes of two infants with cystic fibrosis, including presence of the vas deferens, born to a woman with cystic fibrosis taking CFTR modulators during both pregnancies Kowalik, Aleksandra

23 5 p. 1027-1030
artikel
10 Comparative sensitivity of early cystic fibrosis lung disease detection tools in school aged children Bayfield, Katie J

23 5 p. 918-925
artikel
11 Concentrations of dehydroepiandrosterone-sulphate (DHEA-S) in people with cystic fibrosis on and off elexacaftor-tezacaftor-ivacaftor Abid, Shadaan

23 5 p. 874-877
artikel
12 Correlation between trough concentration and AUC for elexacaftor, tezacaftor and ivacaftor Vonk, Steffie E.M.

23 5 p. 1007-1009
artikel
13 Demographic factors associated with within-individual variability of lung function for adults with cystic fibrosis: A UK registry study Palma, Marco

23 5 p. 936-942
artikel
14 Direct healthcare costs in the first 2 years of life: A comparison of screened and clinically diagnosed children with cystic fibrosis – The Irish comparative outcomes study of CF (ICOS) Somerville, Rebecca

23 5 p. 896-902
artikel
15 Education, employment, and income among people living with cystic fibrosis across three decades – A matched cohort study using Danish health registries Jensen, Camilla Bjørn

23 5 p. 836-841
artikel
16 E-learning within the European cystic fibrosis society - A multidisciplinary cross-sectional survey Smith, C.

23 5 p. 1020-1023
artikel
17 Elexacaftor/tezacaftor/ivacaftor improves nasal nitric oxide in patients with cystic fibrosis Pioch, Charlotte O.

23 5 p. 863-869
artikel
18 Estimating minimal clinically important difference (MCID) for gastrointestinal symptoms in cystic fibrosis Lee, MinJae

23 5 p. 991-999
artikel
19 Feasibility and accuracy of at-home glucose tolerance tests for cystic fibrosis related diabetes screening Alexandre-Heymann, Laure

23 5 p. 857-862
artikel
20 Gut microbiota in adults with cystic fibrosis: Implications for the severity of the CFTR gene mutation and nutritional status Durda-Masny, Magdalena

23 5 p. 977-983
artikel
21 Health care resource utilization preceding death or lung transplantation in people with cystic fibrosis Guyot, Erika

23 5 p. 903-909
artikel
22 Impact of COVID-19 infection on lung function and nutritional status amongst individuals with cystic fibrosis: A global cohort study Semenchuk, Julie

23 5 p. 815-822
artikel
23 Impact of day-to-day variation in FEV1 on measures of change: A conceptual description Magaret, Amalia S.

23 5 p. 943-946
artikel
24 Impact of extended Elexacaftor/Tezacaftor/Ivacaftor therapy on the gut microbiome in cystic fibrosis Marsh, Ryan

23 5 p. 967-976
artikel
25 Impact of interruption of CFTR modulator therapies Capraz Yavuz, Burcu

23 5 p. 947-949
artikel
26 Lung structural and functional impairments in young children with cystic fibrosis diagnosed following newborn screening – A nationwide observational study Frauchiger, Bettina S.

23 5 p. 910-917
artikel
27 Measuring the burden of cystic fibrosis: A scoping review Cheema, Zain M.

23 5 p. 823-830
artikel
28 News article
23 5 p. 813-814
artikel
29 Potential of pharmacogenetics in minimizing drug therapy problems in cystic fibrosis Chhibber, Anindit

23 5 p. 1010-1019
artikel
30 Quantifying abnormal alveolar microstructure in cystic fibrosis lung disease via hyperpolarized 129Xe diffusion MRI Bdaiwi, Abdullah S.

23 5 p. 926-935
artikel
31 Role for DPP4 inhibitor therapy in cystic fibrosis related diabetes: A single centre experience Santhakumar, Anjali

23 5 p. 853-856
artikel
32 Symptoms and quality of life in adults with cystic fibrosis: A cross-sectional analysis of the InSPIRe:CF trial Smirnova, Natalia

23 5 p. 831-835
artikel
33 Table of Content
23 5 p. i-iii
artikel
34 The clinical effectiveness of elexacaftor/tezacaftor/ivacaftor (ETI) for people with CF without a F508del variant: A systematic review and meta-analysis Lupas, Daniel

23 5 p. 950-958
artikel
35 Widespread alterations in systemic immune profile are linked to lung function heterogeneity and airway microbes in cystic fibrosis Rossi, Elio

23 5 p. 885-895
artikel
                             35 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland